Determinants of left ventricular hypertrophy in hypertensive patients: Identification of high-risk patients by metabolic, vascular, and inflammatory risk factors

International Journal of Angiology

Volumn 22, Issue 4, 2013, Pages 223-228

  Peer, Maya ^a   Boaz, Mona ^b   Zipora, Matas ^c   Shargorodsky, Marina ^c  

^a Department of Internal Medicine   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

cardiovascular disease; cardiovascular risk factors; creatinine; high sensitivity C reactive protein; hypercholesterolemia; hypertension

Indexed keywords

ALDOSTERONE; C REACTIVE PROTEIN; ENDOTHELIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN; TRIACYLGLYCEROL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DOPPLER ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HORMONE ACTION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERVENTRICULAR SEPTUM THICKNESS; KIDNEY FUNCTION; LIPID BLOOD LEVEL; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OXIDATIVE STRESS; POSTERIOR WALL THICKNESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; ULTRASOUND TRANSDUCER;

EID: 84888019562     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0033-1348880     Document Type: Article

References (15)

1. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med: 1990; 322 22 1561 1566
2. Palmieri V., de Simone G., Roman M. J., Schwartz J. E., Pickering T. G., Devereux R. B. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension: 1999; 34 5 1032 1040
3. Anan F., Yonemochi H., Masaki T., et al. High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res: 2007; 30 2 125 131
4. Devereux R. B. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension: 1987; 9 (2 Pt 2, Suppl 2): II19 II26
5. Iwashima Y., Horio T., Kuroda S., Takishita S., Kawano Y. Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res: 2002; 25 1 49 56
6. Muscholl M. W., Schunkert H., Muders F., et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J: 1998; 135 1 58 66
7. Murro D. G., Beavers M., Harshfield G. A., Kapuku G. K. Aldosterone contributes to elevated left ventricular mass in black boys. Pediatr Nephrol: 2013; 28 4 655 660
8. Velagaleti R. S., Gona P., Levy D., et al. Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation: 2008; 118 22 2252 2258
9. Schmidt B. MW, Schmieder R. E. Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens: 2003; 16 1 80 86
10. Johnston C. I. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension: 1994; 23 2 258 268
11. Hülsmann M., Stanek B., Frey B., et al. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol: 1998; 32 6 1695 1700
12. Latini R., Masson S., Anand I., et al. Val-HeFT Investigators The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J: 2004; 25 4 292 299
13. Teerlink J. R. Endothelins: pathophysiology and treatment implications in chronic heart failure. Curr Heart Fail Rep: 2005; 2 4 191 197
14. Watanabe K., Sekiya M., Tsuruoka T., Funada J., Kameoka H. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens: 1999; 17 8 1153 1160
15. Galvan A. Q., Galetta F., Natali A., et al. Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation: 2000; 102 18 2233 2238